Raúl Martín-Ruiz is currently Investment Director at Ysios Capital and chairman of the board of STAT Diagnostica. Ysios is a leading Spanish independent venture capital firm that provides private equity financing to early- and mid-stage human healthcare and biotechnology companies. Prior to joining Ysios in 2008, Raúl worked at Laboratorios Almirall where he was responsible for managing and developing the company’s business through licensees and distributors in America and Africa. Before that, he worked in Almirall’s corporate business development department, focusing on in- and out-licensing. At Almirall he interacted with numerous pharmaceutical and biotech companies on a global basis and coordinated and led evaluation and approval several licensing projects in different therapeutic areas, from the technical, commercial, contractual, financial and business perspectives. Raúl began his career in research. He worked on central nervous system pharmacology in the department of pharmacology of the University of the Basque Country (UPV/EHU), and on neurochemistry in the department of neurochemistry of the Institute for Biomedical Research of Barcelona - Spanish National Research Council (CSIC). Raúl holds a bachelor’s of science in biological sciences from UPV/EHU and a PhD in neurosciences from UPV/EHU and CSIC.